Home / News / Company / Maximizing Throughput and Compliance in Pharmaceutical Dissolution Testing

Maximizing Throughput and Compliance in Pharmaceutical Dissolution Testing

By RAYTOR
2026-06-08
Share:

In pharmaceutical R&D and quality control, efficiency and data integrity are non-negotiable. Traditional dissolution setups often bottleneck workflows when managing multiple formulations or comparative studies.

Introducing the Raytor Instruments RT614-ST 14-Vessel Automated Dissolution System—engineered to achieve Smarter Dissolution.

By integrating an innovative dual-group independent configuration, the RT614-ST enables:
🔹 Dual RPM Flexibility: Run synchronous parallel testing with two independent speed zones, effectively doubling throughput.
🔹 Uncompromised Precision & Zero Contamination: High-accuracy servo motors combined with specialized inert fluidics prevent cross-contamination.
🔹 Robust Data Integrity: Smart self-recovery features that automatically resume tests and protect data during unexpected power interruptions.

🤝 Join Us at CPHI & PMEC China 2026 We invite global pharmaceutical professionals, formulation scientists, and QA/QC experts to explore the future of automated laboratory solutions. Let's discuss how Raytor can streamline your regulatory compliance and drug development pipelines.

🗓️ Date: 16-18 June 2026
📍 Location: Shanghai New International Expo Centre (SNIEC), Shanghai, China
🎪 Booth: Hall W16, Booth W16A18

Can’t make it to Shanghai? Contact us today to schedule a virtual consultation or request a technical brochure.